Concordance of ETS fusion status of matched metastatic castration-resistant prostate cancer and primary prostate cancer: Data from NCI 9012, a randomized ETS fusion-stratified phase II trial.
Year: 2014
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Lakshmi Priya Kunju, Nallasivam Palanisamy, Stephanie Daignault, Rohit Mehra, Javed Siddiqui, Shannon Lea Carskadon, Przemyslaw Twardowski, Mark N. Stein, Noah M. Hahn, Walter Michael Stadler, Jon Jacobson, Matthew S. Davenport, Scott A. Tomlins, Arul M. Chinnaiyan, Felix Yi-Chung Feng, Maha Hussain
Institutions: U-M Rogel Cancer Center, University of Michigan, Michigan Center for Translational Pathology, City Of Hope National Medical Center, City of Hope, Rutgers Cancer Institute, Indiana University Health, Indiana University Indianapolis, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, University of Chicago, Michigan Medicine
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2792788308